Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Diseases

Explore clinical trials studying Neuromuscular Diseases. Study availability and eligibility vary by location and protocol.

7,111 public trials 1,301 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Diseases trial results

Active, Not Recruiting

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT05101148

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Rochester, Minnesota, United States
  • Research Site Akron, Ohio, United States
  • Research Site Bydgoszcz, Poland
  • Research Site Gdansk, Poland
View Trial Details
Active, Not Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

NCT06359041

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis, Department of Neurology Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

NCT05633459

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Universitaire Ziekenhuizen Leuven (UZ Leuven) Leuven, Belgium
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • Sunnybrook Health Science Centre Toronto, Ontario, Canada
View all 15 locations
View Trial Details
Active, Not Recruiting

Myasthenia Gravis Inebilizumab Trial

NCT04524273

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Viela Bio Investigative Site - 1015 Orange, California, United States
  • Viela Bio Investigative Site - 1002 New Haven, Connecticut, United States
  • Viela Bio Investigative Center - 1024 Washington D.C., District of Columbia, United States
  • Viela Bio Investigative Site - 1005 Tampa, Florida, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

NCT06450639

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Fractures, Bone, +13 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Children's Healthcare of Atlanta Center for Advanced Pediatrics Atlanta, Georgia, United States
  • Corewell Health Grand Rapids, Michigan, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

NCT01089101

Conditions
Astrocytoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +25 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions